Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggressive hydration with lactated Ringer’s solution versus Plasma solution for prevention of post-ERCP pancreatitis
KCT0008359Phase 4Completed
- Sponsor
- HK inno.N Corporation
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lactated ringer's solution, plasmalyte in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by HK inno.N Corporation. Started Jun 2023; status: completed.
02
Drugs
lactated ringer's solutionplasmalyte
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on KCT0008359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008359.